PADMAJA REDDY BOJANAPALLY M.D NPI 1790949576

NPI Information

  • NPI: 1790949576
  • Provider Name: PADMAJA REDDY BOJANAPALLY, M.D
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1100 MEADE ST
    DUNMORE, PA
    ZIP 18512
  • Phone: (570) 342-3675

Map and Directions

Get Directions

NPI Details

Padmaja Reddy Bojanapally, M.D is a hematology and oncology internal medicine in Dunmore, PA with 26 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Padmaja Reddy Bojanapally, M.D NPI is 1790949576. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

1100 MEADE ST
DUNMORE, PA
ZIP 18512-169
Phone: (570) 342-3675

The NPI 1790949576 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • Magnesium level (HCPCS:83735)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Uric acid level, blood (HCPCS:84550)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Reticulated (young) platelet measurement (HCPCS:85055)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)

The enumeration date for this NPI number is 7/11/2008 and was last updated on 10/1/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal Medicine046458CONNECTICUTNo
2207RH0003XInternal MedicineHematology & OncologyMD448977PENNSYLVANIAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.